Please provide your email address to receive an email when new articles are posted on . Those who received ctDNA testing before tissue diagnosis had median time to treatment of 39 days vs. 62 days for ...

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E This study used the Flatiron ...

Testing blood samples from patients with advanced non–small cell lung cancer (NSCLC) for tumor mutations prior to their receiving a confirmed diagnosis via tissue biopsy can help shorten the time to ...

(Denver, Colo.—July 14, 2025) -- A multidisciplinary guideline panel convened by the American Association of Bronchology and Interventional Pulmonology (AABIP) and the Early Detection & Screening ...

Please provide your email address to receive an email when new articles are posted on . Diagnostic yield was comparable between navigational bronchoscopy and CT-guided biopsy. Trial investigator ...

A head-to-head study from Medtronic showed that its minimally invasive approach to reaching tissues in the lung suspected of harboring cancer could be just as effective as the current standard of care ...

The technology allows medics to reach small spots on the lungs that would usually be left to be monitored, speeding up ...

Air embolism represents a rare but critical complication associated with percutaneous lung biopsy procedures. During these procedures, air may inadvertently enter the vascular system, potentially ...

MADIGAN ARMY MEDICAL CENTER, Joint Base Lewis-McChord, Wash. -- Madigan Army Medical Center has become one of the first Military Treatment Facilities (MTF) to adopt the cutting-edge Ion endoluminal ...

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E Studies have investigated the early use of ...